Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis2018-01-17T17:05:05-05:00
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis2018-01-17T17:00:50-05:00
